Ticker Details
Bristol-Myers Squibb Co. Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
IPO Date:	December 31, 1981
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$118.32B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.48 | 1.09%
Avg Daily Range (30 D):	$0.89 | 1.57%
Avg Daily Range (90 D):	$0.78 | 1.35%

Institutional Daily Volume
Avg Daily Volume:	9.36M
Avg Daily Volume (30 D):	8.64M
Avg Daily Volume (90 D):	8.24M

Trade Size
Avg Trade Size (Sh.):	174
Avg Trade Size (Sh.) (30 D):	82
Avg Trade Size (Sh.) (90 D):	81

Institutional Trades
Total Institutional Trades:	130,723
Avg Institutional Trade:	$5.18M
Avg Institutional Trade (30 D):	$9.84M
Avg Institutional Trade (90 D):	$10.64M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	22

Market Closing Trades
Avg Closing Trade:	$58.82M
Avg Closing Trade (30 D):	$190.96M
Avg Closing Trade (90 D):	$156.35M
Avg Closing Volume:	1.1M

News

Jul 7, 2026 @ 10:30 PM 2 Dirt Cheap Dividend Stocks to Buy With $1,000 Ri... Source: Prosper Junior Bakiny

Jul 3, 2026 @ 11:54 AM Exploring the Cancer Metabolism-Based Therapeutics... Source: Researchandmarkets.Com

Jun 26, 2026 @ 3:30 PM Bristol Myers Squibb vs. Johnson & Johnson: Which ... Source: Sara Appino

Jun 23, 2026 @ 12:00 PM Questex’s PODD, the Premier Gathering for D... Source: Not Specified

Jun 22, 2026 @ 10:10 PM Should You Buy Moderna Before Aug. 5? Source: Adria Cimino

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.47	$.54	$3.47
Diluted EPS	$3.46	$.53	$3.46
Revenue	$48.19B	$12.5B	$48.19B
Gross Profit	$34.26B	$8.41B	$34.26B
Net Income / Loss	$7.06B	$1.09B	$7.06B
Operating Income / Loss	$9.33B	$1.47B	$9.33B
Cost of Revenue	$13.94B	$4.1B	$13.94B
Net Cash Flow	$-129M	$-5508M	$-129M
PE Ratio